Molecular anisms of activity-dependent synapse reduction were studied In an in vitro mam an neuromuscular preparation. Synapse reduction in this model is activity-dependent and is substantially reduced by the broadSpectruID protease Inhibitor, leupeptin, suging the role of activity-dependent proteolytic action in the process. Our present experiments show that a potent and specific thrombin inhibitor, hirudin, at nanomoar concentration completely blocked the activity-dependent synapse reduction. Furthermore, a naturally occuing serine protease inhibitor, protease nexin I (PNI), which closely colocalize with acetylchoflne receptors at the neuromuscular junction, inhibited the synapse reduction at the same low concentration. In contrast, neither cystatin, a cysteine protease inhibitor, nor aproti-n, a serine protease inhibitor that does not inhibit thrombin, blocked the synapse reduction.Simiiariy, neither of the inhibitors of the calcium-activated proteases calpain I and H prevented the reduction of synapses. These results starngly s t that serine proteolytic action by thrombin or thrombin-like molecules is required for synapse reduction in our in vitro model ofthe mammalian neuromuscular jcion.Synapse remodeling is a critical process during development of the nervous system and neuromuscular junction (1). This remodeling involves a substantial reduction, typically 40%, of the synapses initially established. Although it has long been known that this process is activity-dependent (2), the cellular and molecular mechanism of the process is not yet clear.Recently, increasing evidence suggests that some endogenous proteases and protease inhibitors might participate in the regulation of development of the central and peripheral nervous system. These molecules may be involved in important processes such as neurite outgrowth (3), synaptic plasticity (4), and degeneration due to age or injury in the nervous system (5). The action of calcium-activated proteases has been put forward (6-8) as one of several hypotheses for the basis of activity-dependent synapse reduction at the neuromuscular junction (9).To further investigate the molecular mechanisms involved in activity-dependent synapse reduction, we developed an in vitro model by forming neuromuscular junctions in a threecompartment chamber culture system. Our previous results showed that in this culture system, cholinergic synaptic connections were reduced by about 50% after 24 hr of stimulation (10), indicating that the synapse reduction in this system is activity-dependent. A protease inhibitor, leupeptin, at 10 nM concentration, blocked more than 60%o of the activity-dependent synapse reduction (11), suggesting that proteolytic action is involved in the process. We now report that the application of a variety of protease inhibitors to this model system shows that thrombin is an essential mediator of activity-dependent synapse reduction at these neuromuscularjunctions. Preliminary reports of this work have appeared (12, 13).
MATERIALS AND METHODSCell Culture. ...